Understanding how T cells affect COVID-19 severity
T cell modulation of COVID-19 disease
This study is looking at how certain immune cells, called CD8 T cells, affect how serious COVID-19 symptoms can get, using monkeys to see what happens when these cells are removed, and the goal is to help improve treatments for patients based on what they learn about the immune response to the virus.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Tulane University of Louisiana NIH-funded |
| Lab location | 1 site (New Orleans, United States) |
| Project ID | NIH-10674085 on NIH RePORTER |
What this research studies
This research investigates the role of specific immune cells, particularly CD8 T cells, in determining the severity of COVID-19 symptoms. By using a model involving rhesus macaques, the researchers will deplete these immune cells to observe how their absence affects the body's ability to clear the virus. The study aims to clarify the immune mechanisms that differentiate mild cases from severe cases of COVID-19, which could lead to better treatment strategies. Patients may benefit from insights gained about immune responses to the virus.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have been infected with SARS-CoV-2 and exhibit varying degrees of symptoms.
Not a fit: Patients who have not been infected with SARS-CoV-2 or those with mild symptoms that do not require further investigation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for COVID-19 by enhancing our understanding of immune responses.
How similar studies have performed: Other research has shown that understanding immune responses can significantly impact treatment strategies for viral infections, suggesting potential success for this approach.
Where this research is happening
New Orleans, United States
- Tulane University of Louisiana — New Orleans, United States (Active)
Researchers
- Principal investigator: Maness, Nicholas James — Tulane University of Louisiana
- Study coordinator: Maness, Nicholas James
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.